 Marie Jette
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Larynx | 4 | 2020 | 47 | 1.300 |
Why?
| | Vocal Cords | 7 | 2017 | 25 | 1.030 |
Why?
| | Gastroesophageal Reflux | 3 | 2016 | 234 | 0.950 |
Why?
| | Chemoreceptor Cells | 2 | 2020 | 55 | 0.810 |
Why?
| | Laryngeal Mucosa | 2 | 2019 | 5 | 0.720 |
Why?
| | Respiration Disorders | 1 | 2020 | 69 | 0.690 |
Why?
| | Vocal Cord Paralysis | 1 | 2019 | 21 | 0.680 |
Why?
| | Laryngostenosis | 1 | 2019 | 20 | 0.680 |
Why?
| | Arytenoid Cartilage | 1 | 2019 | 4 | 0.660 |
Why?
| | Airway Obstruction | 1 | 2020 | 168 | 0.620 |
Why?
| | Deglutition Disorders | 1 | 2019 | 119 | 0.610 |
Why?
| | Laryngopharyngeal Reflux | 2 | 2018 | 13 | 0.590 |
Why?
| | Acids | 1 | 2016 | 16 | 0.550 |
Why?
| | Cough | 3 | 2022 | 107 | 0.540 |
Why?
| | Cicatrix | 2 | 2015 | 50 | 0.540 |
Why?
| | Immunity, Mucosal | 1 | 2016 | 84 | 0.510 |
Why?
| | Bacteria | 3 | 2017 | 726 | 0.470 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 342 | 0.450 |
Why?
| | Microbiota | 2 | 2017 | 648 | 0.410 |
Why?
| | Smoking | 1 | 2016 | 1384 | 0.330 |
Why?
| | Postoperative Complications | 1 | 2019 | 2127 | 0.330 |
Why?
| | Fibroblasts | 2 | 2013 | 838 | 0.330 |
Why?
| | Voice Disorders | 3 | 2011 | 20 | 0.270 |
Why?
| | Phonation | 4 | 2015 | 5 | 0.240 |
Why?
| | Middle Aged | 12 | 2022 | 26757 | 0.230 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1635 | 0.220 |
Why?
| | Aged | 8 | 2021 | 19094 | 0.200 |
Why?
| | Laryngoscopy | 2 | 2014 | 93 | 0.190 |
Why?
| | Laryngeal Nerves | 1 | 2020 | 5 | 0.180 |
Why?
| | Dysphonia | 2 | 2018 | 10 | 0.180 |
Why?
| | Voice Training | 2 | 2018 | 5 | 0.180 |
Why?
| | Apnea | 1 | 2020 | 17 | 0.180 |
Why?
| | Voice Quality | 2 | 2010 | 15 | 0.180 |
Why?
| | Reflex | 1 | 2020 | 64 | 0.180 |
Why?
| | Young Adult | 7 | 2021 | 10463 | 0.180 |
Why?
| | Electromyography | 3 | 2011 | 326 | 0.180 |
Why?
| | Brain Stem | 1 | 2020 | 101 | 0.170 |
Why?
| | Lasers, Gas | 1 | 2019 | 5 | 0.170 |
Why?
| | Acoustics | 2 | 2010 | 46 | 0.170 |
Why?
| | Adult | 10 | 2021 | 30548 | 0.170 |
Why?
| | Cost of Illness | 1 | 2021 | 254 | 0.160 |
Why?
| | Humans | 20 | 2022 | 114757 | 0.160 |
Why?
| | Nerve Fibers | 1 | 2019 | 87 | 0.160 |
Why?
| | Laser Therapy | 1 | 2019 | 100 | 0.160 |
Why?
| | Female | 14 | 2022 | 59507 | 0.160 |
Why?
| | Cadaver | 1 | 2019 | 299 | 0.150 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2017 | 485 | 0.150 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 250 | 0.150 |
Why?
| | Laryngitis | 1 | 2017 | 3 | 0.140 |
Why?
| | Cell Proliferation | 2 | 2015 | 2196 | 0.140 |
Why?
| | Disease Management | 1 | 2021 | 560 | 0.140 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2017 | 440 | 0.140 |
Why?
| | DNA, Ribosomal | 1 | 2016 | 79 | 0.140 |
Why?
| | Taste Buds | 1 | 2019 | 209 | 0.130 |
Why?
| | Male | 11 | 2021 | 55579 | 0.130 |
Why?
| | Respiratory System | 1 | 2017 | 137 | 0.130 |
Why?
| | Smoke | 1 | 2016 | 123 | 0.130 |
Why?
| | Cigarette Smoking | 1 | 2016 | 72 | 0.130 |
Why?
| | DNA, Bacterial | 1 | 2016 | 310 | 0.120 |
Why?
| | Cluster Analysis | 1 | 2016 | 460 | 0.120 |
Why?
| | Respiratory Mucosa | 1 | 2017 | 251 | 0.120 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2015 | 153 | 0.120 |
Why?
| | Quality of Life | 2 | 2022 | 2358 | 0.120 |
Why?
| | Immune Tolerance | 1 | 2016 | 328 | 0.120 |
Why?
| | Esophageal pH Monitoring | 1 | 2014 | 23 | 0.120 |
Why?
| | Myofibroblasts | 1 | 2015 | 116 | 0.120 |
Why?
| | Linear Models | 1 | 2016 | 770 | 0.110 |
Why?
| | Manometry | 1 | 2014 | 89 | 0.110 |
Why?
| | Blotting, Western | 2 | 2015 | 1151 | 0.110 |
Why?
| | Electric Impedance | 1 | 2014 | 100 | 0.110 |
Why?
| | Sequence Analysis, DNA | 1 | 2016 | 728 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2014 | 197 | 0.110 |
Why?
| | Phylogeny | 1 | 2016 | 794 | 0.110 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 4625 | 0.110 |
Why?
| | Homeostasis | 1 | 2016 | 575 | 0.110 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2014 | 511 | 0.100 |
Why?
| | Communication Disorders | 1 | 2012 | 7 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 316 | 0.100 |
Why?
| | Macrophage Activation | 1 | 2012 | 164 | 0.100 |
Why?
| | Molecular Biology | 1 | 2012 | 56 | 0.100 |
Why?
| | Sex Factors | 1 | 2016 | 1717 | 0.090 |
Why?
| | Animals | 4 | 2020 | 31762 | 0.090 |
Why?
| | Retrospective Studies | 4 | 2021 | 12515 | 0.090 |
Why?
| | Laryngeal Muscles | 1 | 2010 | 5 | 0.090 |
Why?
| | Actins | 1 | 2013 | 381 | 0.090 |
Why?
| | Speech Disorders | 1 | 2010 | 30 | 0.090 |
Why?
| | Voice | 1 | 2010 | 8 | 0.090 |
Why?
| | Neck Muscles | 1 | 2010 | 11 | 0.090 |
Why?
| | Palpation | 1 | 2010 | 12 | 0.090 |
Why?
| | Gene Expression Profiling | 2 | 2015 | 1521 | 0.090 |
Why?
| | Leukocytes, Mononuclear | 1 | 2012 | 493 | 0.090 |
Why?
| | Auditory Perception | 1 | 2010 | 102 | 0.080 |
Why?
| | Age Factors | 1 | 2016 | 2890 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2014 | 2763 | 0.080 |
Why?
| | Hyaluronic Acid | 1 | 2010 | 188 | 0.080 |
Why?
| | Anti-Bacterial Agents | 1 | 2017 | 1477 | 0.070 |
Why?
| | Risk Assessment | 1 | 2016 | 2973 | 0.070 |
Why?
| | Genomics | 1 | 2012 | 639 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2539 | 0.070 |
Why?
| | Prognosis | 1 | 2014 | 3334 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 4409 | 0.070 |
Why?
| | Communication | 1 | 2012 | 747 | 0.070 |
Why?
| | Proteomics | 1 | 2012 | 843 | 0.070 |
Why?
| | Chronic Disease | 2 | 2022 | 1590 | 0.060 |
Why?
| | Macrophages | 1 | 2012 | 1261 | 0.060 |
Why?
| | Mice | 1 | 2019 | 14916 | 0.050 |
Why?
| | Reference Values | 2 | 2015 | 742 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 545 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2018 | 119 | 0.040 |
Why?
| | Health Status | 1 | 2022 | 723 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2015 | 1699 | 0.040 |
Why?
| | Airway Remodeling | 1 | 2017 | 57 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2015 | 3890 | 0.030 |
Why?
| | Mucous Membrane | 1 | 2017 | 108 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2017 | 155 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2017 | 301 | 0.030 |
Why?
| | Sus scrofa | 1 | 2015 | 45 | 0.030 |
Why?
| | X-Ray Microtomography | 1 | 2015 | 73 | 0.030 |
Why?
| | Freezing | 1 | 2015 | 85 | 0.030 |
Why?
| | Models, Anatomic | 1 | 2015 | 87 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 98 | 0.030 |
Why?
| | Swine | 1 | 2017 | 700 | 0.030 |
Why?
| | Inflammation | 2 | 2017 | 2481 | 0.030 |
Why?
| | Dogs | 1 | 2015 | 334 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2017 | 994 | 0.030 |
Why?
| | Species Specificity | 1 | 2015 | 545 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1013 | 0.030 |
Why?
| | Biopsy | 1 | 2017 | 1040 | 0.030 |
Why?
| | Collagen | 1 | 2015 | 415 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2021 | 9089 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2012 | 82 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2012 | 201 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2015 | 513 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2012 | 430 | 0.020 |
Why?
| | Speech Acoustics | 1 | 2011 | 9 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1691 | 0.020 |
Why?
| | Speech Production Measurement | 1 | 2010 | 12 | 0.020 |
Why?
| | Loudness Perception | 1 | 2010 | 8 | 0.020 |
Why?
| | Sound Spectrography | 1 | 2010 | 21 | 0.020 |
Why?
| | Phonetics | 1 | 2010 | 46 | 0.020 |
Why?
| | Wound Healing | 1 | 2012 | 258 | 0.020 |
Why?
| | Pulmonary Ventilation | 1 | 2011 | 74 | 0.020 |
Why?
| | Electrodes | 1 | 2010 | 100 | 0.020 |
Why?
| | Judgment | 1 | 2010 | 55 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 6350 | 0.020 |
Why?
| | Injections | 1 | 2010 | 159 | 0.020 |
Why?
| | Speech | 1 | 2010 | 68 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 812 | 0.020 |
Why?
| | Observer Variation | 1 | 2010 | 295 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 4901 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 17808 | 0.020 |
Why?
| | Language | 1 | 2010 | 261 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 1796 | 0.020 |
Why?
| | Cytokines | 1 | 2012 | 1843 | 0.020 |
Why?
| | United States | 1 | 2017 | 12176 | 0.010 |
Why?
| | Prospective Studies | 1 | 2010 | 6217 | 0.010 |
Why?
|
|
Jette's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|